- Home
- SNY vs BBVA Comparison
SNY vs BBVA Comparison
Compare SNY & BBVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNY
- BBVA
- Stock Information
- Founded
- SNY 1994
- BBVA 1857
- Country
- SNY France
- BBVA Spain
- Employees
- SNY N/A
- BBVA N/A
- Industry
- SNY Biotechnology: Pharmaceutical Preparations
- BBVA Commercial Banks
- Sector
- SNY Health Care
- BBVA Finance
- Exchange
- SNY Nasdaq
- BBVA Nasdaq
- Market Cap
- SNY 116.1B
- BBVA 103.6B
- IPO Year
- SNY N/A
- BBVA N/A
- Fundamental
- Price
- SNY $49.11
- BBVA $18.57
- Analyst Decision
- SNY Buy
- BBVA Buy
- Analyst Count
- SNY 4
- BBVA 1
- Target Price
- SNY $61.50
- BBVA N/A
- AVG Volume (30 Days)
- SNY 3.9M
- BBVA 1.0M
- Earning Date
- SNY 10-24-2025
- BBVA 10-30-2025
- Dividend Yield
- SNY 3.25%
- BBVA 3.37%
- EPS Growth
- SNY 118.56
- BBVA 16.75
- EPS
- SNY 8.65
- BBVA 2.07
- Revenue
- SNY $53,714,621,258.00
- BBVA $36,849,089,843.00
- Revenue This Year
- SNY $1.53
- BBVA $16.65
- Revenue Next Year
- SNY $7.06
- BBVA $2.83
- P/E Ratio
- SNY $5.69
- BBVA $9.08
- Revenue Growth
- SNY 15.65
- BBVA 4.59
- 52 Week Low
- SNY $44.62
- BBVA $9.23
- 52 Week High
- SNY $60.12
- BBVA $19.42
- Technical
- Relative Strength Index (RSI)
- SNY 54.77
- BBVA 47.85
- Support Level
- SNY $44.62
- BBVA $19.01
- Resistance Level
- SNY $51.05
- BBVA $19.42
- Average True Range (ATR)
- SNY 0.83
- BBVA 0.24
- MACD
- SNY 0.43
- BBVA -0.10
- Stochastic Oscillator
- SNY 68.73
- BBVA 0.60
About SNY Sanofi ADS
Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for approximately 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.
About BBVA Banco Bilbao Vizcaya Argentaria S.A.
Despite its Spanish origins, BBVA generates only around a quarter of its profits in Spain. We expect that on a normalised basis, BBVA's market-leading Mexican bank should contribute half of its earnings, while its Turkish operation should account for another 15%. The balance of BBVA's earnings comes from smaller operations in South America. BBVA is overwhelmingly a retail and commercial bank, with corporate and investment banking forming a minor part of the overall business. BBVA also offers insurance and investment products through its banking networks.